Cann Group logo
CAN
Pharmaceuticals, Biotechnology & Life Sciences

Cann Group

Short interest
<0.01%
−4.39 pp 30d
as of 23 Oct 2026
Reported shorts
262
Shares on issue
1.661B

Cann Group (CAN) financials

Results, ratios and statements

Latest result

Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency

Revenue
$9.3M (source: ASX (Markit))vs $13.2M (source: ASX (Markit)) (FY25)
ASX (Markit), as at 29 Oct 2026
NPAT
$20.6M (source: ASX (Markit))vs −$22.3M (source: ASX (Markit)) (FY25)
ASX (Markit), as at 29 Oct 2026
EPS (diluted)
$0.016vs −$0.042 (source: Derived: trailing 12 months at year end) (FY25)
Yahoo Finance, as at 29 Oct 2026
Rev YoY
−29.7%FY
EPS YoY
n/aFY

EPS: prior loss, now profit (growth is not meaningful against a loss).

  • ASX (Markit)
  • Derived: trailing 12 months at year end

Summary of Annual Report to shareholders, 30 Sep 2026

Cann Group reported a statutory net profit of $20.6 million for FY2026, swinging from a $22.3 million loss last year, driven by a one-off $55.7 million debt forgiveness gain, while revenue fell 24% to $8.6 million. No dividend was declared. On an underlying basis, the loss narrowed 21% to $14.7 million, and management guided for FY2027 priorities of growing export volumes, holding costs at an annualised ~$11.5 million run-rate, and refinancing ahead of the December 2027 debt maturity.

Automated summary of the filing; the filing itself is the record.

Key ratios

Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 28 Oct 2026

Gross margin
n/a
Operating margin
n/a
Net margin
221.6%
FCF margin
n/a
ROE
n/a
ROA
n/a
FCF conversion
n/a
Net debt (excl. leases)
n/a
Net debt / EBITDA
n/a
Current ratio
n/a
Interest cover
n/a
Cash dividends paid / net profit
n/a
Market cap
n/a (no share count we can vouch for)
P/E
0.2×
P/B
n/a (no share count we can vouch for)

Ratios use the reporting currency (AUD); market cap is in AUD. Sources: Yahoo Finance and ASX (Markit), as at 29 Oct 2026.

Financial statements

Figures in AUD, the reporting currency; Yahoo Finance unless marked

CAN income, newest period first, figures in AUD
Line itemFY26FY25FY24FY23
Revenue$9.3M (source: ASX (Markit))$13.2M (source: ASX (Markit))$15.4M$13.8M
Gross profitn/an/a$15.4M$13.8M
Operating incomen/an/a−$27.5M−$36.6M
EBITDAn/an/a−$33.4M−$18.7M
EBITn/an/a−$44.4M−$30.6M
Interest expensen/an/a$6.8M$3.2M
Pretax incomen/an/a−$51.2M−$33.8M
Taxn/an/a$0$0
NPAT$20.6M (source: ASX (Markit))−$22.3M (source: ASX (Markit))−$51.2M−$33.8M
Net interest incomen/an/a−$6.8M−$3.2M
EPS basic$0.016−$0.042 (source: Derived: trailing 12 months at year end)−$0.11−$0.086
EPS diluted$0.016−$0.042 (source: Derived: trailing 12 months at year end)−$0.11−$0.086
Sharesn/an/a471.3M410.8M
  • ASX (Markit)
  • Derived: trailing 12 months at year end